CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Viral Breakthrough in HbeAg-Negative Chronic Hepatitis B Patients Receiving Lamivudine Therapy

Clin Mol Hepatol. 2002;8(4):397-404. Published online 1970 January 1

470 HBeAg negative patients with chronic hepatitis B are less likely to have A biochemical breakthrough during lamivudine treatment

Journal of Hepatology. 2005;42:170

Link1 Link2

504 Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistant patients with HBeAg-negative chronic hepatitis B

Journal of Hepatology. 2005;42:182

Link1 Link2

510 HBsAg levels under interferon and lamivudine therapy in HBeAg-negative chronic hepatitis B (CHBe-) patients

Journal of Hepatology. 2005;42:185

Link1 Link2

Viral Breakthrough during Lamivudine Therapy for Chronic Hepatitis B

Nancy Leung

Intervirology. 2003;46(6):344-349

Link1 Link2

1178 Effect of the precore mutations on the HBEAG loss and viral breakthrough during lamivudine therapy in HBEAG-positive chronic hepatitis B

S KIM, Y HWANG, K KWON, M JUNG, D PARK, O KWON, S KWON, Y KIM, Y KOO, Y KIM

Hepatology. 2003;38:723-723

Link1 Link2

Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients

R. Idilman, K. Cinar, G. Seven, Y. Bozkus, A. Elhan, M. Bozdayi, C. Yurdaydin, K. Bahar

Journal of Viral Hepatitis. 2011;19(3):220-226

Link1 Link2

Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

D.R. Snydman

Yearbook of Medicine. 2007;2007:80-81

Link1 Link2

Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

G.A. Makar

Yearbook of Gastroenterology. 2007;2007:253-255

Link1 Link2

Entecavir Versus Lamivudine for Patients With HBeAg-Negative Chronic Hepatitis B

J.A. Stockman

Yearbook of Pediatrics. 2007;2007:276-278

Link1 Link2

Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences

C Liu

Hepatology. 2001;34(3):583-589

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.